CITI Good Clinical Practice Course (US FDA focus) Exam | Verified
Exam Questions and Answers | Latest Updated Study Material 2026
Question:
CITI Good Clinical Practice Course (US FDA focus) Exam
The data access section of the CTA defines:
Answer:
The various study
roles and which study roles have access to what data
Question:
The budget for a clinical trial:
Answer:
Is often benchmarked using data
from third party providers like a fair market value (FMV) alignment
Question:
The CTA's confidentiality clause describes:
Answer:
Handling of
proprietary information
Question:
In the CTA's subject injury section, it will usually specify that if a subject in a clinical trial gets
hurt, then:
Answer:
Treatment for such injuries will always be available
at the site
Question:
The confidential information from the study:
Answer:
Must be protected
for the duration indicated in the CTA
, Question:
Indemnification is defined as:
Answer:
Defining the duties and
responsibilities of the parties in cases of loss or injury linked to the clinical trial
Question:
Which of the following CTA terms could be a major risk area for the study site?
Answer:
Indemnification of the researcher, study staff, and officers of the organization
Question:
The Records/Reporting section of the CTA should define the following:
Answer:
How documents are to be secured and archived
Question:
The CTA may contain a generalized monitoring plan. The researcher and site should request a
more detailed monitoring plan section to include:
Answer:
How often the
monitor will visit the site and any specific times
Question:
The researcher needs to be involved in the review of the CTA for the following reasons:
Answer:
The researcher understands the nuances of the trial.
Question:
Geographic location of the study site is important for the budget because:
Answer:
The costs of procedures and services may vary by location.
Exam Questions and Answers | Latest Updated Study Material 2026
Question:
CITI Good Clinical Practice Course (US FDA focus) Exam
The data access section of the CTA defines:
Answer:
The various study
roles and which study roles have access to what data
Question:
The budget for a clinical trial:
Answer:
Is often benchmarked using data
from third party providers like a fair market value (FMV) alignment
Question:
The CTA's confidentiality clause describes:
Answer:
Handling of
proprietary information
Question:
In the CTA's subject injury section, it will usually specify that if a subject in a clinical trial gets
hurt, then:
Answer:
Treatment for such injuries will always be available
at the site
Question:
The confidential information from the study:
Answer:
Must be protected
for the duration indicated in the CTA
, Question:
Indemnification is defined as:
Answer:
Defining the duties and
responsibilities of the parties in cases of loss or injury linked to the clinical trial
Question:
Which of the following CTA terms could be a major risk area for the study site?
Answer:
Indemnification of the researcher, study staff, and officers of the organization
Question:
The Records/Reporting section of the CTA should define the following:
Answer:
How documents are to be secured and archived
Question:
The CTA may contain a generalized monitoring plan. The researcher and site should request a
more detailed monitoring plan section to include:
Answer:
How often the
monitor will visit the site and any specific times
Question:
The researcher needs to be involved in the review of the CTA for the following reasons:
Answer:
The researcher understands the nuances of the trial.
Question:
Geographic location of the study site is important for the budget because:
Answer:
The costs of procedures and services may vary by location.
